Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients